Bavarian Nordic A/S (OTCMKTS:BVNRY) Shares Pass Below Two Hundred Day Moving Average – Here’s Why

Bavarian Nordic A/S (OTCMKTS:BVNRY)’s share price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $8.46 and traded as low as $8.20. Bavarian Nordic A/S shares last traded at $8.24, with a volume of 1,996 shares traded.

Bavarian Nordic A/S Trading Up 1.5%

The company has a market cap of $1.95 billion, a PE ratio of 11.94 and a beta of 1.44. The firm has a 50 day moving average of $7.66 and a two-hundred day moving average of $8.44.

Bavarian Nordic A/S (OTCMKTS:BVNRY) last released its quarterly earnings data on Friday, May 9th. The company reported $0.13 earnings per share (EPS) for the quarter. The business had revenue of $189.89 million for the quarter. Bavarian Nordic A/S had a return on equity of 10.65% and a net margin of 18.33%. On average, research analysts forecast that Bavarian Nordic A/S will post 0.67 EPS for the current year.

Bavarian Nordic A/S Company Profile

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.